scholarly article | Q13442814 |
review article | Q7318358 |
P2093 | author name string | Bai Lu | |
Keri Martinowich | |||
P2860 | cites work | Sortilin is essential for proNGF-induced neuronal cell death | Q24312692 |
Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. | Q24532072 | ||
Genetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior | Q24679793 | ||
Regulation of cell survival by secreted proneurotrophins | Q27919620 | ||
BDNF-mediated neurotransmission relies upon a myosin VI motor complex | Q28510749 | ||
DNA Methylation-Related Chromatin Remodeling in Activity-Dependent Bdnf Gene Regulation | Q28591717 | ||
Mechanism of TrkB-mediated hippocampal long-term potentiation | Q28592383 | ||
Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 | Q28941210 | ||
Cortical inhibitory neurons and schizophrenia | Q29547683 | ||
The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function | Q29615582 | ||
Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action | Q29615696 | ||
Neurotrophins and hippocampal synaptic transmission and plasticity | Q33734778 | ||
BDNF and activity-dependent synaptic modulation | Q33820669 | ||
Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor | Q33932396 | ||
Calcium regulation of neuronal gene expression | Q33944216 | ||
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology | Q33991750 | ||
Association study of a brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and personality trait and intelligence in healthy young females | Q34290743 | ||
The yin and yang of neurotrophin action | Q34439423 | ||
Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia | Q35618342 | ||
Brain-derived neurotrophic factor modulates hippocampal synaptic transmission by increasing N-methyl-D-aspartic acid receptor activity | Q36290217 | ||
Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. | Q38320374 | ||
ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. | Q40414334 | ||
Multiple promoters direct tissue-specific expression of the rat BDNF gene | Q41569141 | ||
Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus | Q42527742 | ||
Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons | Q43435250 | ||
Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia | Q43590751 | ||
BDNF mRNA expression in rat hippocampus and prefrontal cortex: effects of neonatal ventral hippocampal damage and antipsychotic drugs | Q43698142 | ||
Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase | Q43768755 | ||
Differential regulation of hippocampal BDNF mRNA by typical and atypical antipsychotic administration | Q44189362 | ||
Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia | Q44507092 | ||
Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. | Q44885119 | ||
Cleavage of proBDNF by tPA/plasmin is essential for long-term hippocampal plasticity | Q45108268 | ||
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. | Q45221811 | ||
Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons | Q45235102 | ||
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression | Q46604995 | ||
The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. | Q46776170 | ||
A role for BDNF in the late-phase of hippocampal long-term potentiation | Q47684335 | ||
Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. | Q47724311 | ||
The C270T polymorphism of the brain-derived neurotrophic factor gene is associated with schizophrenia | Q48142556 | ||
Human brain derived neurotrophic factor (BDNF) genes, splicing patterns, and assessments of associations with substance abuse and Parkinson's Disease | Q48153435 | ||
Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway | Q48354828 | ||
Neurotrophin expression in rat hippocampal slices: a stimulus paradigm inducing LTP in CA1 evokes increases in BDNF and NT-3 mRNAs | Q48400173 | ||
Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients | Q48541290 | ||
The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills | Q48667441 | ||
Sorting and activity-dependent secretion of BDNF require interaction of a specific motif with the sorting receptor carboxypeptidase e. | Q49124948 | ||
The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology. | Q51935722 | ||
Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice. | Q52201421 | ||
Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus | Q59085769 | ||
Brain-derived neurotrophic factor serum concentrations are increased in drug-naïve schizophrenic patients with chronic cannabis abuse and multiple substance abuse | Q60640489 | ||
Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients | Q73978751 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
schizophrenia | Q41112 | ||
P304 | page(s) | 119-29; discussion 129-35, 193-5 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Novartis Foundation symposium | Q26853854 |
P1476 | title | Cell biology of BDNF and its relevance to schizophrenia | |
P478 | volume | 289 |
Q36600804 | A Review of Brain-derived Neurotrophic Factor as a Candidate Biomarker in Schizophrenia |
Q30498950 | Activity-dependent brain-derived neurotrophic factor expression regulates cortistatin-interneurons and sleep behavior |
Q48678119 | Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia. |
Q44077531 | Altered expression of histone and synaptic plasticity associated genes in the hippocampus of streptozotocin-induced diabetic mice |
Q38488535 | An association study of the genetic polymorphisms in 13 neural plasticity-related genes with semantic and episodic memories |
Q42356677 | BDNF pro-peptide regulates dendritic spines via caspase-3. |
Q36589545 | BDNF-TrkB signaling and neuroprotection in schizophrenia |
Q33820463 | Biological substrates underpinning diagnosis of major depression |
Q49787166 | Botanicals as Modulators of Neuroplasticity: Focus on BDNF. |
Q60947816 | Brain-Derived Neurotrophic Factor in Central Nervous System Myelination: A New Mechanism to Promote Myelin Plasticity and Repair |
Q51875231 | Brain-derived neurotrophic factor: the neurotrophin hypothesis of psychopathology. |
Q37398019 | Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence |
Q36567277 | DNA Methylation of BDNF Gene in Schizophrenia. |
Q33672712 | Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders |
Q48397485 | Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology |
Q39884103 | Effect of BDNF Val66Met polymorphism on digital working memory and spatial localization in a healthy Chinese Han population |
Q46156029 | Elevated serum S100B protein in first-episode drug-naive Chinese patients with schizophrenia |
Q37346195 | Epigenetic and pharmacoepigenomic studies of major psychoses and potentials for therapeutics. |
Q24654169 | Epigenetic mechanisms in schizophrenia |
Q37565253 | Episodic memory in schizophrenia |
Q39315740 | Expression and methylation of BDNF in the human brain in schizophrenia |
Q39301735 | From Gene to Behavior: L-Type Calcium Channel Mechanisms Underlying Neuropsychiatric Symptoms |
Q34462508 | Functional and structural specific roles of activity-driven BDNF within circuits formed by single spiny stellate neurons of the barrel cortex |
Q48315286 | Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance |
Q35609351 | Genetic association of the Phosphoinositide-3 kinase in schizophrenia and bipolar disorder and interaction with a BDNF gene polymorphism |
Q33516442 | Imaging genetics of structural brain connectivity and neural integrity markers |
Q35975176 | Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats |
Q42508462 | Lack of brain-derived neurotrophic factor hampers inner hair cell synapse physiology, but protects against noise-induced hearing loss. |
Q38264013 | May BDNF Be Implicated in the Exercise-Mediated Regulation of Inflammation? Critical Review and Synthesis of Evidence |
Q48726571 | Modulatory effects of sex steroid hormones on brain-derived neurotrophic factor-tyrosine kinase B expression during adolescent development in C57Bl/6 mice |
Q37541846 | Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia |
Q35687024 | Neurotrophins role in depression neurobiology: a review of basic and clinical evidence |
Q47819976 | Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice |
Q46314942 | Nicotine restores Wt-like levels of reelin and GAD67 gene expression in brain of heterozygous reeler mice |
Q34399243 | Novel implications of Lingo-1 and its signaling partners in schizophrenia |
Q35760210 | Pharmacological activation of group-II metabotropic glutamate receptors corrects a schizophrenia-like phenotype induced by prenatal stress in mice. |
Q30437323 | Progesterone-estrogen interactions in synaptic plasticity and neuroprotection |
Q92070536 | Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways |
Q35877594 | Reactive Transformation and Increased BDNF Signaling by Hippocampal Astrocytes in Response to MK-801 |
Q36529898 | Regulation of brain-derived neurotrophic factor expression in neurons |
Q92510369 | Risperidone Reverses the Downregulation of BDNF in Hippocampal Neurons and MK801-Induced Cognitive Impairment in Rats |
Q47879222 | Sex-specific disruptions in spatial memory and anhedonia in a "two hit" rat model correspond with alterations in hippocampal brain-derived neurotrophic factor expression and signaling |
Q48005756 | The 5-HTTLPR and BDNF polymorphisms moderate the association between uncinate fasciculus connectivity and antidepressants treatment response in major depression |
Q47679266 | The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins |
Q42375090 | The impact of antidepressant treatment on brain-derived neurotrophic factor level: An evidence-based approach through systematic review and meta-analysis |
Search more.